- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orgenesis Inc (ORGS)
Track today's live Orgenesis (ORGS) share price, performance and key data on this page with our current OTC Markets:ORGS stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Orgenesis share price on the OTC Markets exchange. Use the dropdown to switch exchange for the ORGS share price, head to our technical summary section, which provides analysis on Orgenesis share price buy/sell indicators using real-time data (or discuss the Orgenesis (ORGS) stock price today with other investors in the Orgenesis OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC:ORGS share price (ISIN: US68619K3032) to enhance your trading decisions with our free investment tools and resources.
What Is the Orgenesis Inc Share Price Today?
The Orgenesis share price today is 0.004.
What Is the Stock Symbol for Orgenesis Inc
The stock symbol (or 'ticker') for Orgenesis Inc is "ORGS."
What Stock Exchange Does Orgenesis Inc Trade On?
Orgenesis Inc is listed and trades on the OTC Markets stock exchange.
Is Orgenesis Inc a Good Stock to Buy?
Determining whether Orgenesis (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current OTC:ORGS share price (ISIN: US68619K3032) to enhance your trading decisions with our free investment tools and resources.
What Is the Orgenesis Inc Share Price Today?
The Orgenesis share price today is 0.004.
What Is the Stock Symbol for Orgenesis Inc
The stock symbol (or 'ticker') for Orgenesis Inc is "ORGS."
What Stock Exchange Does Orgenesis Inc Trade On?
Orgenesis Inc is listed and trades on the OTC Markets stock exchange.
Is Orgenesis Inc a Good Stock to Buy?
Determining whether Orgenesis (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
OTC Markets
Currency in USD
0.004
+0.003(+300.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.004
0.004
52 wk Range
0.001
1.080
ORGS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0040.004
52 wk Range
0.0011.080
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ORGS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
- Form 8K Orgenesis Inc For: 13 March
- Investing.com
- Form 8K Orgenesis Inc For: 13 March
- Investing.com
- Form 8K Orgenesis Inc For: 26 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
13/11/2024
EPS / Forecast
-1.93 / 0.17
Revenue / Forecast
347K / 18.5M
Compare ORGS to Peers and Sector
Metrics to compare | ORGS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipORGSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −6.3x | −0.4x | |
PEG Ratio | 0.00 | −0.25 | 0.00 | |
Price/Book | 0.0x | 2.7x | 2.6x | |
Price / LTM Sales | 0.0x | 7.5x | 3.0x | |
Upside (Analyst Target) | 0.0% | 81.3% | 53.5% | |
Fair Value Upside | Unlock | −0.1% | 9.0% | Unlock |
Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Orgenesis (OTC Markets: ORGS) Share Price Today?
The Orgenesis stock price today is 0.004 USD.
What Stock Exchange Does Orgenesis (ORGS) Trade On?
Orgenesis is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for Orgenesis?
The stock symbol (also called a 'ticker') for Orgenesis is "ORGS."
What Is the Current Orgenesis Market Capitalisation?
As of today, Orgenesis (OTC Markets: ORGS) market cap is 41.160K USD.
What Is Orgenesis's (ORGS) Earnings Per Share (TTM)?
The Orgenesis EPS is currently -11.438 (Trailing Twelve Months).
Is ORGS a Buy or Sell From a Technical Analyst Perspective?
Based on today's Orgenesis moving averages and other technical indicators, the daily buy/sell signal for ORGS stock is Strong Sell.
How Many Times Has Orgenesis Stock Split?
Orgenesis has split 3 times. (See the ORGS stock split history page for full effective split date and price information.)
How Many Employees Does Orgenesis Have?
Orgenesis has 77 employees, based on their latest Companies House report.
What is the current trading status of Orgenesis (OTC Markets: ORGS)?
As of 19/07/2026, Orgenesis (ORGS) is trading at a share price of 0.004 USD, with a previous close of 0.001 USD. The stock has fluctuated within a day range of 0.004 USD to 0.004 USD, while its 52-week range spans from 0.001 USD to 1.080 USD.
What Is the ORGS After Hours Price?
ORGS's last after hours stock price is 1.850 USD, the stock has decreased by -0.030, or -1.600%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.